Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen M Schoch

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Neuron|June 23, 2017
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative DiseasesKathleen M Schoch, Timothy M Miller
Nature Medicine|April 16, 2021
Is presymptomatic ALS perivascular?Collin J Kreple, Kathleen M Schoch, Timothy M Miller
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 25, 2012
Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injuryKathleen M Schoch, Sindhu K Madathil, Kathryn E Saatman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 2, 2022
Antisense Oligonucleotides for the Study and Treatment of ALSBenjamin D Boros, Kathleen M Schoch, Collin J Kreple, et al.
Molecular and Cellular Neurosciences|July 24, 2025
Ubiquitous calpastatin overexpression in brain-injured mice attenuates motor and cognitive behavioral deficits without overt neuroprotectionKathleen M Schoch, Dominic N Nthenge-Ngumbau, Jennifer M Brelsfoard, et al.
Journal of Neurochemistry|January 12, 2013
Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouseKathleen M Schoch, Catherine R von Reyn, Jifeng Bian, et al.
Experimental Neurology|May 11, 2012
Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injuryKathleen M Schoch, Heather N Evans, Jennifer M Brelsfoard, et al.
Neurobiology of Disease|April 2, 2013
Calpains mediate axonal cytoskeleton disintegration during Wallerian degenerationMarek Ma, Toby A Ferguson, Kathleen M Schoch, et al.
Annals of Neurology|January 11, 2023
Protective Effects of Lovastatin in a Population-Based ALS Study and Mouse ModelCollin J Kreple, Susan Searles Nielsen, Kathleen M Schoch, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2026
miR-146a is a pleiotropic regulator of motor neuron degenerationDylan A Galloway, Hunter L Patterson, Mariah L Hoye, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Neuron|June 23, 2017
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative DiseasesKathleen M Schoch, Timothy M Miller
Nature Medicine|April 16, 2021
Is presymptomatic ALS perivascular?Collin J Kreple, Kathleen M Schoch, Timothy M Miller
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 25, 2012
Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injuryKathleen M Schoch, Sindhu K Madathil, Kathryn E Saatman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 2, 2022
Antisense Oligonucleotides for the Study and Treatment of ALSBenjamin D Boros, Kathleen M Schoch, Collin J Kreple, et al.
Molecular and Cellular Neurosciences|July 24, 2025
Ubiquitous calpastatin overexpression in brain-injured mice attenuates motor and cognitive behavioral deficits without overt neuroprotectionKathleen M Schoch, Dominic N Nthenge-Ngumbau, Jennifer M Brelsfoard, et al.
Journal of Neurochemistry|January 12, 2013
Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouseKathleen M Schoch, Catherine R von Reyn, Jifeng Bian, et al.
Experimental Neurology|May 11, 2012
Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injuryKathleen M Schoch, Heather N Evans, Jennifer M Brelsfoard, et al.
Neurobiology of Disease|April 2, 2013
Calpains mediate axonal cytoskeleton disintegration during Wallerian degenerationMarek Ma, Toby A Ferguson, Kathleen M Schoch, et al.
Annals of Neurology|January 11, 2023
Protective Effects of Lovastatin in a Population-Based ALS Study and Mouse ModelCollin J Kreple, Susan Searles Nielsen, Kathleen M Schoch, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2026
miR-146a is a pleiotropic regulator of motor neuron degenerationDylan A Galloway, Hunter L Patterson, Mariah L Hoye, et al.
Pageof 3